AwardedFinlandGoods
Nusinerseeni (Spinraza 28mg ja 50mg)-valmisteiden valinta ajalle 15.5.2026-31.12.2027 Pohteen lääkehankintarenkaalle
- Published
- Published 17 April 2026
Overview
Biogen Finland Oy has been awarded the supply of Nusinerseeni (Spinraza 28mg and 50mg) injection solution for the treatment of spinal muscular atrophy related to chromosome 5q for the Pohteen pharmaceutical procurement network from 15 May 2026 to 31 December 2027. The award was made on 6 May 2026.
Key details
- Country
- Finland
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 17 April 2026
Pharmaceutical products
Award outcome
- Awarded value
- €1
- Award date
- 6 May 2026
- Biogen Finland Oy
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
12 May 2026
Contract Notice
17 April 2026
Contracting authority
Pohjois-Pohjanmaan hyvinvointialue
Procuring entityPOHDE, Finland
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.